Expert analyst Patrick Trucchio has spent many years researching the psychedelic drug stock sector. Patrick Trucchio, CFA, is a Managing Director of Equity Research at H.C. Wainwright & Co. whose ...

Tiago Reis Marques, M.D., Ph.D. is the Chief Executive Officer of Pasithea Therapeutics Corp. Dr. Marques is a fellow at Imperial College London and a lecturer at the Institute of Psychiatry, King ...

So, it’s been a few years since you last spoke with The Wall Street Transcript. Let’s start with a refresher about the company and its history and how it’s evolved over the years. Mr. Groesbeck: I’ll ...

Let’s start with a brief history of the company and its focus on accessories for cannabis. Ms. Sher: Sure. So Greenlane is the leading global omnichannel platform for the development and distribution ...

Ahmad Doroudian, Ph.D., is Chief Executive Officer and Director of BetterLife Pharma Inc. Dr. Doroudian is an accomplished executive with over 25 years’ experience in management and development ...

Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF) Ahmad Doroudian Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF) Robert Beasley Interview with the CEO: Greenlane Holdings ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Let’s start with a brief overview of the company, including some major milestones. Mr. Beasley: Cansortium is a publicly traded company, which is a Canadian registered entity on the Ontario Exchange.

Please introduce your firm, your role, and what you cover in terms of the psychedelics market. Mr. Trucchio: I work at H.C. Wainwright, an investment bank headquartered in New York, as a senior health ...